| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |